Validación y uso de la técnica del linfonodo centinela axilar con colorante exclusivo en pacientes con cáncer de mama

Background: The use of a dye and radiocolloid to detect sentinel lymph nodes in breast cáncer increases the detection rates. However the use of either method alone does not modify the false negative rate. Therefore there is no formal contraindication for the exclusive use of dye to detect nodes. Aim...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Bühler H,Simón, Rojas P,Hugo, Cayazzo M,Daniela, Cunill C,Eduardo, Vesperinas A,Gonzalo, Hamilton S,James
Lenguaje:	Spanish / Castilian
Publicado:	Sociedad Médica de Santiago 2008
Materias:	Breast neoplasms Reactive blue dye Sentinel lymph node biopsy
Acceso en línea:	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872008000800008
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:scielo:S0034-98872008000800008
record_format	dspace
spelling	oai:scielo:S0034-988720080008000082009-01-23Validación y uso de la técnica del linfonodo centinela axilar con colorante exclusivo en pacientes con cáncer de mamaBühler H,SimónRojas P,HugoCayazzo M,DanielaCunill C,EduardoVesperinas A,GonzaloHamilton S,James Breast neoplasms Reactive blue dye Sentinel lymph node biopsy Background: The use of a dye and radiocolloid to detect sentinel lymph nodes in breast cáncer increases the detection rates. However the use of either method alone does not modify the false negative rate. Therefore there is no formal contraindication for the exclusive use of dye to detect nodes. Aim: To repon a prospective analysis of the exclusive blue dye technique for sentinel node biopsy in patients with early breast cáncer Patients and methods: We analyzed the first 100 women with pathologically proven breast cáncer who met the inclusión criteria. Patent blue dye was used as colorant. In the first 25 cases sentinel node was identified using radiocolloid and blue dye an then an axillary dissection perfomed. In the next 25 women, blue dye was used exclusively for detection and an axillary dissection was perfomed. In the next 50 cases, blue dye was used and only isolated sentinel node biopsy was perfomed. Results: In 92 of the 100 women a sentinel node was successfully detected. In the first 50 women, the false negative rate of sentinel lymph node detection was 6.9%. No complications occurred. During follow-up, lasting three to 29 months, no axillary relapse was observed. Conclusions: Sentinel node biopsy in patients with early breast cáncer using exclusively blue dye is feasible and safe.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.136 n.8 20082008-08-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872008000800008es10.4067/S0034-98872008000800008
institution	Scielo Chile
collection	Scielo Chile
language	Spanish / Castilian
topic	Breast neoplasms Reactive blue dye Sentinel lymph node biopsy
spellingShingle	Breast neoplasms Reactive blue dye Sentinel lymph node biopsy Bühler H,Simón Rojas P,Hugo Cayazzo M,Daniela Cunill C,Eduardo Vesperinas A,Gonzalo Hamilton S,James Validación y uso de la técnica del linfonodo centinela axilar con colorante exclusivo en pacientes con cáncer de mama
description	Background: The use of a dye and radiocolloid to detect sentinel lymph nodes in breast cáncer increases the detection rates. However the use of either method alone does not modify the false negative rate. Therefore there is no formal contraindication for the exclusive use of dye to detect nodes. Aim: To repon a prospective analysis of the exclusive blue dye technique for sentinel node biopsy in patients with early breast cáncer Patients and methods: We analyzed the first 100 women with pathologically proven breast cáncer who met the inclusión criteria. Patent blue dye was used as colorant. In the first 25 cases sentinel node was identified using radiocolloid and blue dye an then an axillary dissection perfomed. In the next 25 women, blue dye was used exclusively for detection and an axillary dissection was perfomed. In the next 50 cases, blue dye was used and only isolated sentinel node biopsy was perfomed. Results: In 92 of the 100 women a sentinel node was successfully detected. In the first 50 women, the false negative rate of sentinel lymph node detection was 6.9%. No complications occurred. During follow-up, lasting three to 29 months, no axillary relapse was observed. Conclusions: Sentinel node biopsy in patients with early breast cáncer using exclusively blue dye is feasible and safe.
author	Bühler H,Simón Rojas P,Hugo Cayazzo M,Daniela Cunill C,Eduardo Vesperinas A,Gonzalo Hamilton S,James
author_facet	Bühler H,Simón Rojas P,Hugo Cayazzo M,Daniela Cunill C,Eduardo Vesperinas A,Gonzalo Hamilton S,James
author_sort	Bühler H,Simón
title	Validación y uso de la técnica del linfonodo centinela axilar con colorante exclusivo en pacientes con cáncer de mama
title_short	Validación y uso de la técnica del linfonodo centinela axilar con colorante exclusivo en pacientes con cáncer de mama
title_full	Validación y uso de la técnica del linfonodo centinela axilar con colorante exclusivo en pacientes con cáncer de mama
title_fullStr	Validación y uso de la técnica del linfonodo centinela axilar con colorante exclusivo en pacientes con cáncer de mama
title_full_unstemmed	Validación y uso de la técnica del linfonodo centinela axilar con colorante exclusivo en pacientes con cáncer de mama
title_sort	validación y uso de la técnica del linfonodo centinela axilar con colorante exclusivo en pacientes con cáncer de mama
publisher	Sociedad Médica de Santiago
publishDate	2008
url	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872008000800008
work_keys_str_mv	AT buhlerhsimon validacionyusodelatecnicadellinfonodocentinelaaxilarconcoloranteexclusivoenpacientesconcancerdemama AT rojasphugo validacionyusodelatecnicadellinfonodocentinelaaxilarconcoloranteexclusivoenpacientesconcancerdemama AT cayazzomdaniela validacionyusodelatecnicadellinfonodocentinelaaxilarconcoloranteexclusivoenpacientesconcancerdemama AT cunillceduardo validacionyusodelatecnicadellinfonodocentinelaaxilarconcoloranteexclusivoenpacientesconcancerdemama AT vesperinasagonzalo validacionyusodelatecnicadellinfonodocentinelaaxilarconcoloranteexclusivoenpacientesconcancerdemama AT hamiltonsjames validacionyusodelatecnicadellinfonodocentinelaaxilarconcoloranteexclusivoenpacientesconcancerdemama
_version_	1718436396150030336

Validación y uso de la técnica del linfonodo centinela axilar con colorante exclusivo en pacientes con cáncer de mama

Ejemplares similares